This text investigates the transition of targeted anti-cancer therapies from experimental scientific research into standard clinical oncology practice. The authors, Kevin Harrington and Konstantinos N. Syrigos, synthesize a vast body of emerging literature to provide a comprehensive framework for understanding how molecular-level interventions are currently being applied to treat malignant cells. The book serves as a bridge between laboratory discovery and bedside application, offering a structured overview of the current state of precision medicine in oncology.

Experts identify this work as a specialized reference text tailored for molecular oncologists and researchers involved in clinical trial development. Readers frequently note the technical density of the prose, which is designed to support professionals navigating the rapid evolution of targeted cancer treatments.